Previous studies reported an association between PPARGC1A polymorphism at position +1564G/A (rs8192678) with NAFLD, which is associated with the replacement of Gly with Ser (Gly482Ser) [10–12]. Here, PPARGC1A is linked to metabolic dysfunction-associated steatotic liver disease.